학술논문

The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy.
Document Type
journal article
Source
BMC Surgery; 7/22/2016, Vol. 16, p1-13, 13p
Subject
RENAL cell carcinoma
TISSUE wounds
PROGRESSION-free survival
POSTOPERATIVE care
METASTASIS
CANCER treatment
PROTEIN kinase inhibitors
HEPATECTOMY
KIDNEY tumors
PROGNOSIS
PROTEIN-tyrosine kinases
SURVIVAL
RETROSPECTIVE studies
CHEMICAL inhibitors
TUMOR treatment
THERAPEUTICS
Language
ISSN
14712482
Abstract
Copyright of BMC Surgery is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)